Dr. David Huntsman
Director, Ovarian Cancer Research Program

Dr. Huntsman is Professor, Pathology and Laboratory Medicine, UBC; Medical Director, Centre for Translational and Applied Genomics, BC Cancer Agency; Co-Founder and Acting-Director, OvCaRe; Co-Director, Genetic Pathology Evaluation Centre, VGH; Associate Director, Hereditary Cancer Program, BC Cancer Agency; and member of Vancouver Coastal Health Research Institute.

Dr. Huntsman was part of the team that discovered EMSY, a new gene related to ovarian cancer.  His current focus of study is the genetic predisposition to ovarian cancer. His research focuses on understanding the molecular differences between the different ovarian cancer subtypes, which will hopefully lead to more specific treatments.  Recently, he headed the research group that discovered a new mutation in a gene called FOXL2, which appears to be responsible for the development of granulosa cell tumours of the ovary.

Dr. Huntsman has active research programs in the development of predictive and prognostic tissue-based cancer biomarkers of a wide variety of tumour types as well as hereditary gastric cancer. As collaboration is critical in his field, Dr. Huntsman happily leads and engages in a wide number of multidisciplinary research groups.

You can read Dr. Huntsman's blog posts here.

Blog Posts by Dr. David Huntsman

Displaying 1 - 7 of 7 blog posts

Ovarian cancer research propelled by philanthropy

Much of the progress we have been able to achieve to date within the Ovarian Cancer Research (OVCARE) program has been possible thanks to our many partnerships. Indeed, mentioned in my first blog, the nature of OVCARE as a multi-disciplinary, multi-institution research group makes partnership inherent to our success. In fact, our partnerships extend beyond the medical and scientific communities to include patients their families and the philanthropic organizations that support us. Maintaining and building on these partnerships will be essential as we embark on our fifteen year plan of...

Dr. Huntsman: "It's an absence of a story that we want to create"

I was truly inspired by the outpouring of support at Hope Couture this week, where over $600,000 was raised for research into the prevention of ovarian cancer, specifically for the Ovarian Cancer Research (OVCARE) program. The London-themed luncheon reminded me of the very humble beginnings of OVCARE. What is now a world-leading, multi-disciplinary and multi-institution research group began at a Chinese restaurant over a decade ago thanks to the single-minded determination of Dr. Dianne Miller, our clinical leader. But OVCARE's rapid evolution from an idea of a team to one of the top three...

Teamwork drives ovarian cancer research

Hello, My name is Dr. David Huntsman and it is a pleasure to return as guest blogger for the BC Cancer Foundation. It has been several years since my last blog, and a lot has happened with regard to ovarian cancer research at the BC Cancer Agency. British Columbia’s Ovarian Cancer Research Program (OVCARE) first began over a dinner conversation with my colleague Dr. Dianne Miller, the head of gynecological oncology at the BC Cancer Agency. She was tired of seeing women dying from ovarian cancer and demanded that clinicians and researchers work more effectively as a team to put an end to this...

Dr. Huntsman looking to the future of OvCaRe – an internationally recognized entity

Our first five-year plan for the Ovarian Cancer Research program (OvCaRe) is nearly complete. During these first five years, OvCaRe has grown from an idea into an internationally recognized team. We have exceeded all of our expectations of the program’s success. I believe this is because of the collaborative spirit that exists within our team and the firm partnership we have established with our patients and the BC Cancer Foundation. We have a new five-year plan now that enables OvCaRe to increase the scope of our discoveries and bring our discoveries into the clinic – to improve the lives of...

Dr. David Huntsman and the success of OvCaRe

Since the beginning of the Ovarian Cancer Research (OvCaRe) program, the team has expanded; we have multiple new investigators, and have won national and international awards. We have grown from a small group of researchers and disconnected research projects to a coherent team that is recognized internationally as a leader in the study of ovarian cancer. I believe our success stems from three things. First, our team works because we want to work together and we share a vision of a world free from ovarian cancer. Second, the environment we work in is superb. The BC Cancer Agency brings the...

Dr. David Huntsman and the modest beginning of OvCaRe

I still remember when the Ovarian Cancer Research (OvCaRe) program was born. Dr. Dianne Miller, the head of our Gynecologic Tumour Group at the BC Cancer Agency, had called a meeting for anyone in Vancouver who was interested in studying ovarian cancer. We met at a Chinese restaurant, and after dinner, Dianne declared that she was so tired of seeing women dying of this cancer and felt that if we work together we could really do something about it. I remember looking around the table and realizing I was surrounded by people that I admired professionally and saw no reason why we should not only...

About Dr. David Huntsman and ovarian cancer research

Hello! My name is David Huntsman, and I’m a pathologist and clinical cancer geneticist at the BC Cancer Agency Vancouver Centre. I have the great privilege of running our Ovarian Cancer Research (OvCaRe) team, and this month I’d like to share more about the OvCaRe program with you, from how it started to where it’s headed. First, I’ll share how and why I chose to study ovarian cancer. Originally, I was certain my destiny was to become a rural family doctor, while attending medical school at Memorial University in Newfoundland. After medical school, I worked in Western Labrador for two years...